Seoul National University Hospital
Seoul, KS013, South Korea
NCT Number: NCT05649319
This prospective, randomized, open-labeled study is designed to evaluate the impact of enhanced recovery after surgery (ERAS) protocol on postoperative quality of recovery in patients undergoing laparoscopic distal gastrectomy. We hypothesize that our ERAS protocol can significantly improve the postoperative quality of recovery in patients with laparoscopic distal gastrectomy.
Looking for future studies?
Notify Me19 year–80 year
All sexes
Interventional
Not applicable
Seoul, KS013, South Korea
Adult patients undergoing elective laparoscopic distal gastrectomy are randomly allocated to receive the ERAS protocol (n=49) or conventional protocol (n=49). The conventional groups receive our current perioperative management. The ERAS groups receive our new ERAS protocol including preoperative carbohydrate loading, shortening of perioperative fasting time, and multimodal opioid-sparing analgesia. The primary outcome measure was the postoperative quality of recovery evaluated using the Korean version of Quality of recovery-15 at 24, 48, and 72 hours postoperatively. The secondary outcome measures were pain intensity at rest and during coughing evaluated using an 11-point numeric rating scale at 24, 48, and 72 hours postoperatively, gastrointestinal dysfunction evaluated using the I-FEED score at 24, 48, and 72 hours postoperatively, the occurrence of postoperative nausea and vomiting during the first postoperative 24 hours, postoperative 24 to 48 hour period, and postoperative 48 to 72 hour period, the occurrence of major postoperative complications according to the Clavien-Dindo classification during hospitalization, and length of hospital stay.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The ERAS protocol involves a pre-admission patient education using audiovisual videos, the reduction of perioperative fasting time with administration of preoperative carbohydrate loading and early resumption of oral feeding after surgery, multimodal postoperative nausea and vomiting prevention, early removal of the nasogastric tube and urinary catheter, and multimodal analgesia to minimize opioid consumption after surgery.
Time frame: postoperative 24, 48, and 72 hours
Korean version of Quality of recovery-15 questionnaire (0-150): 0, "very poor recovery"; 150, "excellent recovery"
Time frame: postoperative 24, 48, and 72 hours
11-pointed NRS pain score at resting/coughing NRS (0-10): 0,"no pain"; 10, "worst pain imaginable"
Time frame: From the end of surgery to 24, 48, and 72 hours postoperatively
postoperative fentanyl consumption (mcg) via IV patient controlled analgesia
Time frame: From the end of surgery to 24, 48, and 72 hours postoperatively
Incidence of postoperative nausea and vomiting (%)
Time frame: postoperative 24, 48, and 72 hours
I-FEED score 3 points or more (postoperative gastrointestinal intolerance and dysfunction)
Time frame: Evaluate every hour starting from 9A on the postoperative day 3 up to discharge
Postoperative time satisfying the following four criteria: (1) tolerance of soft blended diet (SBD) for 24 h; (2) safe ambulation of 600 m without assistance; (3) Adequate pain control (NRS ≤ 3) with oral non opioid analgesics; and (4) No abnormal physical findings or laboratory test
Seoul National University Hospital
Other
Effectiveness of Enhanced Recovery After Surgery (ERAS) on Postoperative Recovery After Laparoscopic Distal Gastrectomy: An Open-labeled Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06984952
Digestive System Diseases, Digestive System Neoplasms
Busan, South Korea
View Trial DetailsNCT07095816
Acetaminophen, Analgesic
Nanjing, Jiangsu, China
View Trial DetailsNCT04625283
Anesthesia, Enhanced Recovery After Surgery
Nashville, Tennessee, United States
View Trial DetailsNCT05564819
Acetaminophen, Analgesic
Nanjing, Jiangsu, China
View Trial Details